Vincasar PFS is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Teva Parenteral Medicines, Inc.. The primary component is Vincristine Sulfate.
| Product ID | 0703-4412_1ef63a7e-d056-4213-b48c-b2af2799b199 | 
| NDC | 0703-4412 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Vincasar PFS | 
| Generic Name | Vincristine Sulfate | 
| Dosage Form | Injection, Solution | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 2000-05-01 | 
| Marketing Category | ANDA / ANDA | 
| Application Number | ANDA075493 | 
| Labeler Name | Teva Parenteral Medicines, Inc. | 
| Substance Name | VINCRISTINE SULFATE | 
| Active Ingredient Strength | 1 mg/mL | 
| Pharm Classes | Vinca Alkaloid [EPC],Vinca Alkaloids [CS] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2021-12-31 | 
| Marketing Start Date | 2000-05-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | ANDA | 
| Application Number | ANDA075493 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2000-05-01 | 
| Ingredient | Strength | 
|---|---|
| VINCRISTINE SULFATE | 1 mg/mL | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0703-4402 | Vincasar PFS | vinCRIStine sulfate | 
| 0703-4412 | Vincasar PFS | vinCRIStine sulfate | 
| 20536-322 | Marqibo | Vincristine Sulfate | 
| 72893-008 | Marqibo | Vincristine Sulfate | 
| 61703-309 | VinCRIStine Sulfate | VINCRISTINE SULFATE | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  VINCASAR PFS  73688998  1491918 Live/Registered | ERBAMONT INC. 1987-10-19 |